|
| Press Releases |
|
 |
|
| Friday, August 16, 2024 |
|
|
OrbusNeich Records Net Profit of US$18.8 Million for the First Half of 2024 |
| OrbusNeich Medical Group Holdings Limited ('OrbusNeich' or the 'Group'; stock code: 6929), a major global medical device manufacturer specializing in interventional devices for percutaneous coronary intervention ('PCI') and percutaneous transluminal angioplasty ('PTA') procedures, today announced its interim results for the six months ended June 30, 2024 (the 'Reporting Period), with revenue and profit for the period attributable to owners of the Company maintained at US$78.9 million and US$18.8 million respectively despite various market challenges. more info >> |
|
|
业聚医疗2024年上半年纯利达1,880万美元 |
| 专营经皮冠状动脉介入治疗（PCI）及经皮腔内血管成形术（PTA）手术介入器械的全球主要医疗器械制造商业聚医疗集团控股有限公司（「业聚医疗」或「集团」；股份代号：6929）今天宣布截至2024年6月30日止六个月(「报告期」)的中期业绩。 more info >> |
|
|
業聚醫療2024年上半年純利達1,880萬美元 |
| 專營經皮冠狀動脈介入治療（PCI）及經皮腔內血管成形術（PTA）手術介入器械的全球主要醫療器械製造商業聚醫療集團控股有限公司（「業聚醫療」或「集團」；股份代號：6929）今天宣佈截至2024年6月30日止六個月(「報告期」)的中期業績。 more info >> |
|
| Wednesday, April 24, 2024 |
|
|
业聚医疗合资企业在中国内地启动TricValve临床试验 |
| more info >> |
|
|
業聚醫療合資企業在中國內地啟動TricValve臨床試驗 |
| 專營經皮冠狀動脈介入治療（PCI）及經皮腔內血管成形術（PTA）手術介入器械的全球主要醫療器械製造商業聚醫療集團控股有限公司（「業聚醫療」或「集團」；股份代號：6929）今天公佈，其合資企業業聚培福有限公司（「業聚培福」）旗下用作治療血流動力學相關的三尖瓣功能不全和腔靜脈回流的產品——TricValve經導管雙腔靜脈瓣膜系統（「TricValve」），已於2024年4月22日在中國內地展開臨床試驗。 more info >> |
|
|
OrbusNeich's Joint Venture Kicks Off TricValve Clinical Trial in Mainland China |
| OrbusNeich Medical Group Holdings Limited announced today that the Group's joint venture OrbusNeich P+F Company Limited ("ON P&F") has commenced the clinical trial for the TricValve Transcatheter Bicaval Valve System ("TricValve"), to treat patients with hemodynamically relevant tricuspid insufficiency and caval reflux, on April 22, 2024 across Mainland China. more info >> |
|
| Thursday, March 7, 2024 |
|
|
業聚醫療收入純利雙雙創新高 分別約1.54億美元及4,510萬美元 建議派發末期股息每股10港仙 |
| 專營經皮冠狀動脈介入治療（PCI）及經皮腔內血管成形術（PTA）手術介入器械的全球主要醫療器械製造商業聚醫療集團控股有限公司（「業聚醫療」或「集團」；股份代號：6929），今天公佈截至2023年12月31日止年度的全年業績。 more info >> |
|
|
业聚医疗收入纯利双双创新高 分别约1.54亿美元及4,510万美元 建议派发末期股息每股10港仙 |
| 专营经皮冠状动脉介入治疗（PCI）及经皮腔内血管成形术（PTA）手术介入器械的全球主要医疗器械制造商业聚医疗集团控股有限公司（「业聚医疗」或「集团」；股份代号：6929），今天公布截至2023年12月31日止年度的全年业绩。 more info >> |
|
|
OrbusNeich Achieves Record-High Revenue and Net Profit of US$154 Million and US$45.1 Million Respectively, Recommends Final Dividend Payment of HK10 cents per Share |
| OrbusNeich Medical Group Holdings Limited ("OrbusNeich" or the "Group"; stock code: 6929), a major global medical device manufacturer specializing in interventional devices for percutaneous coronary intervention (PCI) and percutaneous transluminal angioplasty (PTA) procedures more info >> |
|
| Monday, November 27, 2023 |
|
|
业聚医疗拟斥资约1,500万美元收购印尼经销商84%股权 |
| 专营经皮冠状动脉介入治疗（PCI）及经皮腔内血管成形术（PTA）手术介入器械的全球主要医疗器械制造商业聚医疗集团控股有限公司（「业聚医疗」或「集团」；股份代号：6929）欣然宣布，于2023年11月27日，透过旗下全资附属公司收购PT Revass Utama Medika（「PT Revass」） 84% 的已发行股本。 more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
Daeshin MC Co., Ltd.は、産業現場から公共施設まで快適な室内環境を作り出すクリーンソリューションを発表
Nov 22, 2024 12:00: JST
|
|
|
三菱重工、新たな防衛輸送用「機動舟艇」に搭載するウォータージェット推進装置の供給へ
Nov 22, 2024 11:45: JST
|
|
|
Daeshin MC Co., Ltd. Unveils Its Clean Solutions Creating Pleasant Indoor Environments from Industrial Sites to Public Facilities
Nov 22, 2024 11:00 HKT/SGT
|
|
|
Jacobson Pharma Announces FY2025 Interim Results
Nov 22, 2024 10:00 HKT/SGT
|
|
|
雅各臣公佈二零二五財年中期業績 持續經營業務溢利飈升44.2%
Nov 22, 2024 10:00 HKT/SGT
|
|
|
Mailbird Expands to Mac: Popular Windows Email Client Launches Much-Anticipated Mac App
Nov 22, 2024 10:00 HKT/SGT
|
|
|
DesignInspire opens on December 5, with free admission for the public
Nov 22, 2024 09:00 HKT/SGT
|
|
|
アレス・マネジメント、東京オフィス開設でアジア事業を拡充
Nov 22, 2024 09:00: JST
|
|
|
Yahoo Finance Invest Asia 2024 - Disrupting Finance: Innovations Shaping The Future
Nov 22, 2024 08:50 HKT/SGT
|
|
|
NaaS Q3 2024 Recap: Strategic Shifts and Tech Innovations for Growth
Nov 21, 2024 22:59 JST
|
|
|
GMG Unveils SUPER G(R): A Game-Changing Graphene Solution for the Lithium-Ion Battery Industry
Nov 21, 2024 21:29 HKT/SGT
|
|
|
neurocare Group AG Welcomes Kevin Reeder as Chief Financial Officer
Nov 21, 2024 21:20 HKT/SGT
|
|
|
Experience the Power of Movement: Jin Pilates Brings Singapore's First Garuda Studio for Dynamic, Holistic Wellness
Nov 21, 2024 21:00: JST
|
|
|
Experience the Power of Movement: Jin Pilates Brings Singapore's First Garuda Studio for Dynamic, Holistic Wellness
Nov 21, 2024 20:19 HKT/SGT
|
|
|
透雲生物萊茵衣藻獲國家衛健委新用途許可
Nov 21, 2024 19:51 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
